Braveheart Bio Targets $1.2 Billion Valuation in IPO
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
Archive
Search
Nasdaq Hits Record High as Tech Earnings Beat Muted Expectations
Software multiples expanded for the third consecutive quarter, pulling private comparables with them.
Caplight Raises $16 Million for Private-Market Data and Trading Tools
BlackRock and Fin Capital are backing infrastructure that helps investors price, analyze and transact in shares of private companies.
Osanni Bio Raises $190 Million for a Multi-Program Therapeutics Platform
The biotechnology company is advancing seven programs and plans to form focused affiliates as individual assets reach clinical milestones.
OpenAI Files Confidentially for a U.S. Initial Public Offering
The ChatGPT maker joined Anthropic in a high-stakes race to bring frontier AI companies to public markets.
Anthropic Confidentially Files for U.S. IPO
The Claude developer moved ahead of OpenAI as frontier AI companies prepare for public scrutiny.
Cerebras Shares Soar in $5.55 Billion Nasdaq Debut
The AI chipmaker nearly doubled its offering price as investors sought another route into compute infrastructure.
Skydio Raises $110 Million to Expand U.S. Drone Manufacturing
The autonomous drone maker reached a $4.4 billion valuation as it increases production for defense, public safety and infrastructure customers.
OpenAI Closes $122 Billion Round at an $852 Billion Valuation
The financing gives the San Francisco AI company an extraordinary capital base, while placing equal pressure on revenue growth, infrastructure execution and product focus.
